» Authors » Simerjot K Jassal

Simerjot K Jassal

Explore the profile of Simerjot K Jassal including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 7887
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lamprea-Montealegre J, Shapiro A, Bontrager N, Rifkin D, Jassal S, Gregg L, et al.
Kidney Med . 2024 May; 6(6):100830. PMID: 38799784
Rationale & Objective: The measurement of cystatin C has been recommended to enhance chronic kidney disease (CKD) detection and risk stratification in clinical practice. This study gathered insights into the...
2.
Khan S, Matsushita K, Sang Y, Ballew S, Grams M, Surapaneni A, et al.
Circulation . 2023 Nov; 149(6):430-449. PMID: 37947085
Background: Multivariable equations are recommended by primary prevention guidelines to assess absolute risk of cardiovascular disease (CVD). However, current equations have several limitations. Therefore, we developed and validated the American...
3.
Grams M, Coresh J, Matsushita K, Ballew S, Sang Y, Surapaneni A, et al.
JAMA . 2023 Oct; 330(13):1266-1277. PMID: 37787795
Importance: Chronic kidney disease (low estimated glomerular filtration rate [eGFR] or albuminuria) affects approximately 14% of adults in the US. Objective: To evaluate associations of lower eGFR based on creatinine...
4.
Daniel M, Gottlieb M, Wooten D, Stojan J, Haas M, Bailey J, et al.
Med Teach . 2022 Nov; 44(12):1313-1331. PMID: 36369939
Background: The COVID-19 pandemic caused graduate medical education (GME) programs to pivot to virtual interviews (VIs) for recruitment and selection. This systematic review synthesizes the rapidly expanding evidence base on...
5.
Gaziano L, Sun L, Arnold M, Bell S, Cho K, Kaptoge S, et al.
Circulation . 2022 Oct; 146(20):1507-1517. PMID: 36314129
Background: End-stage renal disease is associated with a high risk of cardiovascular events. It is unknown, however, whether mild-to-moderate kidney dysfunction is causally related to coronary heart disease (CHD) and...
6.
Lamprea-Montealegre J, Joshi P, Shapiro A, Madden E, Navarra K, Potok O, et al.
BMC Nephrol . 2022 Oct; 23(1):331. PMID: 36224528
Background: There are major gaps in the implementation of guideline-concordant care for persons with chronic kidney disease (CKD). The CKD Cascade of Care (C) initiative seeks to improve CKD care...
7.
Matsushita K, Kaptoge S, Hageman S, Sang Y, Ballew S, Grams M, et al.
Eur J Prev Cardiol . 2022 Aug; 30(1):8-16. PMID: 35972749
Aims: The 2021 European Society of Cardiology (ESC) guideline on cardiovascular disease (CVD) prevention categorizes moderate and severe chronic kidney disease (CKD) as high and very-high CVD risk status regardless...
8.
Klein R, Koch J, Snyder E, Volerman A, Simon W, Jassal S, et al.
J Gen Intern Med . 2022 Jun; 37(9):2194-2199. PMID: 35710653
Background: Disparities in objective assessments in graduate medical education such as the In-Training Examination (ITE) that disadvantage women and those self-identifying with race/ethnicities underrepresented in medicine (URiM) are of concern....
9.
Shin J, Chang A, Grams M, Coresh J, Ballew S, Surapaneni A, et al.
Hypertension . 2021 Aug; 78(4):1042-1052. PMID: 34365812
[Figure: see text].
10.
Matsushita K, Jassal S, Sang Y, Ballew S, Grams M, Surapaneni A, et al.
EClinicalMedicine . 2020 Nov; 27:100552. PMID: 33150324
Background: Chronic kidney disease (CKD) measures (estimated glomerular filtration rate [eGFR] and albuminuria) are frequently assessed in clinical practice and improve the prediction of incident cardiovascular disease (CVD), yet most...